WHO co-operation plan backs improved Indian role in global health
This article was originally published in Scrip
The World Health Organisation's new country co-operation strategy (CCS) with India (2012-17) aims to support an improved role for the country's government in global health. The strategy identifies various measures including strengthening the pharmaceutical sector, drug regulatory capacity, trade and health so that these can play a "special" role in India's future, and also suggests the implementation of international health regulations and similar global commitments.
You may also be interested in...
Aurobindo and Sandoz mutually terminate their planned $1bn deal, leaving many questions on how both sides will re-orient strategies going forward.
Takeda appoints new country head for India and aims to improve patient access to innovative medicines in the largely out-of-pocket market.
The coronavirus pandemic has thrown up unprecedented challenges for the Indian clinical trials segment, as in other parts of the world. Experts tell Scrip how things are poised in the country including potential impact on some critical milestones, but efforts are underway to tackle the crisis.